person · Reporting owner

Gajendra Sanjay

Disclosed activity across 1 company

Tapewire entity: 21503
SEC CIK: 0001998179

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Astera Labs, Inc.ALAB · Entity 1853	Director · President and COO	August 17, 2026	August 19, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Astera Labs, Inc.

Report date August 17, 2026 · Filed August 19, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,119,038	Ending reported balance After 2026-08-17 transaction · row 18 18 source rows · reconciled sequence Row 1 · 2026-08-17 · Sale · Disposed 578 · Balance 1,209,090 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-08-17 · Sale · Disposed 1,049 · Balance 1,208,041 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-08-17 · Sale · Disposed 1,984 · Balance 1,206,057 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-08-17 · Sale · Disposed 1,057 · Balance 1,205,000 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 5 · 2026-08-17 · Sale · Disposed 3,500 · Balance 1,201,500 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 6 · 2026-08-17 · Sale · Disposed 2,525 · Balance 1,198,975 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 7 · 2026-08-17 · Sale · Disposed 17,373 · Balance 1,181,602 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 8 · 2026-08-17 · Sale · Disposed 3,713 · Balance 1,177,889 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 9 · 2026-08-17 · Sale · Disposed 5,449 · Balance 1,172,440 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 10 · 2026-08-17 · Sale · Disposed 1,610 · Balance 1,170,830 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 11 · 2026-08-17 · Sale · Disposed 2,616 · Balance 1,168,214 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 12 · 2026-08-17 · Sale · Disposed 6,484 · Balance 1,161,730 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 13 · 2026-08-17 · Sale · Disposed 7,992 · Balance 1,153,738 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 14 · 2026-08-17 · Sale · Disposed 10,438 · Balance 1,143,300 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 15 · 2026-08-17 · Sale · Disposed 2,946 · Balance 1,140,354 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 16 · 2026-08-17 · Sale · Disposed 1,782 · Balance 1,138,572 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 17 · 2026-08-17 · Sale · Disposed 6,926 · Balance 1,131,646 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 18 · 2026-08-17 · Sale · Disposed 12,608 · Balance 1,119,038 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Common StockSEC Table I · non-derivative	IndirectBy Trust 1	5,290,402	Reported balance Holding disclosure · report date 2026-08-17 · row 19 Holding and transaction disclosures are not merged. 1 source row Row 19 · Balance 5,290,402 F20: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy Trust 2	615,000	Reported balance Holding disclosure · report date 2026-08-17 · row 20 Holding and transaction disclosures are not merged. 1 source row Row 20 · Balance 615,000 F21: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy Trust 3	615,000	Reported balance Holding disclosure · report date 2026-08-17 · row 21 Holding and transaction disclosures are not merged. 1 source row Row 21 · Balance 615,000 F22: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F20: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F21: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F22: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 01, 2025 Filed Dec 4, 2025 00:45 UTC	Astera Labs, Inc. ALAB · Entity 1853	GiftCommon Stock	71,000	$0.00	$0.00	Disclosure SEC source: 0001998179-25-000008 · wk-form4_1764809143.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 5,935,213 F1 · kind: Represents a bona fide gift of shares to a non-affiliated entity. F2 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:21 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	6,172	$143.25	$884,155.05	Disclosure SEC source: 0001998179-25-000006 · wk-form4_1763587258.xml · nonDerivative · entry 5 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,599,750 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.3450 to $143.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:21 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	32,385	$143.84	$4,658,209.82	Disclosure SEC source: 0001998179-25-000006 · wk-form4_1763587258.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,605,922 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.3400 to $143.3700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:21 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	26,381	$144.80	$3,820,037.39	Disclosure SEC source: 0001998179-25-000006 · wk-form4_1763587258.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,638,307 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.3500 to $144.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:21 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	21,100	$145.88	$3,078,146.07	Disclosure SEC source: 0001998179-25-000006 · wk-form4_1763587258.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,664,688 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.3500 to $145.3700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:21 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	4,421	$146.65	$648,355.57	Disclosure SEC source: 0001998179-25-000006 · wk-form4_1763587258.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,685,788 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.3300 to $146.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
September 02, 2025 Filed Sep 4, 2025 23:06 UTC	Astera Labs, Inc. ALAB · Entity 1853	GiftCommon Stock	480,668	$0.00	$0.00	Disclosure SEC source: 0001736297-25-000128 · wk-form4_1757027164.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 6,006,213 F1 · kind: On September 2, 2025, the Reporting Person transferred 480,668 shares of Issuer Common Stock to an estate planning trust ("Trust 1") for no consideration. F2 · ownership.nature: These shares are owned directly by Trust 1, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
September 02, 2025 Filed Sep 4, 2025 23:06 UTC	Astera Labs, Inc. ALAB · Entity 1853	GiftCommon Stock	480,668	$0.00	$0.00	Disclosure SEC source: 0001736297-25-000128 · wk-form4_1757027164.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,690,209 F1 · kind: On September 2, 2025, the Reporting Person transferred 480,668 shares of Issuer Common Stock to an estate planning trust ("Trust 1") for no consideration. Read SEC document
August 18, 2025 Filed Aug 21, 2025 00:30 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	44,551	$183.17	$8,160,397.76	Disclosure SEC source: 0001736297-25-000117 · wk-form4_1755736217.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,170,877 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $183.4400 to $182.8700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
August 18, 2025 Filed Aug 21, 2025 00:30 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	46,890	$183.83	$8,619,985.64	Disclosure SEC source: 0001736297-25-000117 · wk-form4_1755736217.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,215,428 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $184.4400 to $183.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	3,000	$174.89	$524,660.70	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 10 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,525,545 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F12 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.2900 to $175.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	5,900	$173.73	$1,025,034.73	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 9 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,528,545 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.1700 to $174.1550, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	22,430	$172.53	$3,869,917.43	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 8 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,534,445 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $172.1700 to $173.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	43,127	$171.65	$7,402,909.12	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 7 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,556,875 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.1700 to $172.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	79,591	$170.67	$13,583,437.81	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 6 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,600,002 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.1700 to $171.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	32,363	$169.67	$5,491,133.77	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 5 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,679,593 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.1700 to $170.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	42,149	$168.71	$7,110,898.78	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,711,956 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.1700 to $169.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,478	$167.57	$4,771,958.79	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,754,105 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.1700 to $168.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	17,587	$166.83	$2,934,116.59	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,782,583 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.1700 to $167.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
August 07, 2025 Filed Aug 8, 2025 22:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	5,375	$165.75	$890,922.91	Disclosure SEC source: 0001736297-25-000100 · wk-form4_1754691871.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,800,170 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.1700 to $166.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 23:51 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	20,000	$98.22	$1,964,360.00	Disclosure SEC source: 0001736297-25-000082 · wk-form4_1752277864.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 695,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.3400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 23:51 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	20,000	$98.21	$1,964,156.00	Disclosure SEC source: 0001736297-25-000082 · wk-form4_1752277864.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 695,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.3400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 23:51 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	38,315	$99.21	$3,801,204.33	Disclosure SEC source: 0001736297-25-000082 · wk-form4_1752277864.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,805,545 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.1000 to $99.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
July 09, 2025 Filed Jul 11, 2025 23:51 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	86,685	$98.52	$8,540,327.56	Disclosure SEC source: 0001736297-25-000082 · wk-form4_1752277864.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,843,860 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $99.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:18 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	9,257	$98.20	$909,007.78	Disclosure SEC source: 0001736297-25-000067 · wk-form4_1750709875.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 715,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:18 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	9,257	$98.19	$908,969.82	Disclosure SEC source: 0001736297-25-000067 · wk-form4_1750709875.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 715,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:18 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	4,926	$99.21	$488,691.22	Disclosure SEC source: 0001736297-25-000067 · wk-form4_1750709875.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,930,545 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.1100 to $99.3300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:18 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	52,933	$98.38	$5,207,437.38	Disclosure SEC source: 0001736297-25-000067 · wk-form4_1750709875.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,935,471 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $99.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	10,743	$98.11	$1,053,989.28	Disclosure SEC source: 0001736297-25-000049 · wk-form4_1749241432.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 724,257 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.2200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	10,743	$98.11	$1,053,989.28	Disclosure SEC source: 0001736297-25-000049 · wk-form4_1749241432.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 724,257 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.2200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:24 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	67,141	$98.11	$6,587,163.23	Disclosure SEC source: 0001736297-25-000049 · wk-form4_1749241432.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 5,988,404 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.2200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 27, 2025 Filed May 29, 2025 20:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	20,000	$98.17	$1,963,454.00	Disclosure SEC source: 0001736297-25-000045 · wk-form4_1748551024.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 735,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 27, 2025 Filed May 29, 2025 20:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	20,000	$98.18	$1,963,500.00	Disclosure SEC source: 0001736297-25-000045 · wk-form4_1748551024.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 735,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 27, 2025 Filed May 29, 2025 20:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	125,000	$98.27	$12,283,975.00	Disclosure SEC source: 0001736297-25-000045 · wk-form4_1748551024.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,055,545 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.6100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 16, 2025 Filed May 21, 2025 01:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	39,898	$90.33	$3,604,165.88	Disclosure SEC source: 0001736297-25-000043 · wk-form4_1747790115.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,262,318 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.2400 to $90.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 16, 2025 Filed May 21, 2025 01:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	42,589	$90.67	$3,861,672.40	Disclosure SEC source: 0001736297-25-000043 · wk-form4_1747790115.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,302,216 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.4250 to $91.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 16, 2025 Filed May 21, 2025 01:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,850	$92.15	$815,569.98	Disclosure SEC source: 0001736297-25-000043 · wk-form4_1747790115.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,344,805 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.7300 to $92.5550, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	6,197	$72.44	$448,899.53	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 10 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 755,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F14 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.1000 to $73.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F12 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	11,403	$71.66	$817,143.54	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 9 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 761,197 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F13 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.0900 to $72.0800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F12 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,400	$70.63	$169,501.68	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 8 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 772,600 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.0900 to $71.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F12 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	6,254	$72.44	$453,019.12	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 7 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 755,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.0800 to $73.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	11,287	$71.65	$808,658.24	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 6 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 761,254 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.0800 to $72.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,459	$70.63	$173,689.99	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 5 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 772,541 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.0800 to $71.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	500	$73.14	$36,571.00	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,180,545 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.0500 to $73.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	42,557	$72.38	$3,080,437.38	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,181,045 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.9900 to $72.8200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	68,937	$71.59	$4,935,379.07	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,223,602 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.9900 to $71.9800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,006	$70.57	$917,773.59	Disclosure SEC source: 0001736297-25-000033 · wk-form4_1747085331.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,292,539 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.9900 to $70.9800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
February 19, 2025 Filed Feb 21, 2025 22:34 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	527	$92.35	$48,667.45	Disclosure SEC source: 0001736297-25-000013 · wk-form4_1740177263.xml · nonDerivative · entry 6 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,353,655 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.3450 to $92.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 19, 2025 Filed Feb 21, 2025 22:34 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,051	$91.86	$1,198,894.88	Disclosure SEC source: 0001736297-25-000013 · wk-form4_1740177263.xml · nonDerivative · entry 5 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,354,182 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.3100 to $92.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 19, 2025 Filed Feb 21, 2025 22:34 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	31,152	$90.89	$2,831,495.62	Disclosure SEC source: 0001736297-25-000013 · wk-form4_1740177263.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,367,233 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.3050 to $91.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.